Suppr超能文献

在经皮肾镜取石术患者中,标准化围手术期用药以用于术后加速康复计划是可行的。

Standardizing Perioperative Medications to Be Used in an Enhanced Recovery After Surgery Program Is Feasible in Percutaneous Nephrolithotomy Patients.

作者信息

Girgiss Carol B L, Berger Jonathan H, Chen Tony T, Kelly Erika M, Kong Emily K, Flores Alec R, Abedi Garen, Bechis Seth K, Monga Manoj, Sur Roger L

机构信息

San Diego, School of Medicine, University of California, San Diego, California, USA.

Department of Urology, University of California San Diego Health, San Diego, California, USA.

出版信息

J Endourol. 2022 Oct;36(10):1265-1270. doi: 10.1089/end.2022.0153. Epub 2022 Jun 9.

Abstract

The objective of this process improvement project was to determine the effect of enhanced recovery after surgery (ERAS) protocol for percutaneous nephrolithotomy (PCNL) patients with respect to quality of life (QOL) and pain management in the postoperative recovery period. An electronic-based medical record ERAS orders protocol for PCNL was instituted at an academic medical center in July 2020. The protocol utilized a pain control regimen designed to minimize opioid medication use postoperatively. We prospectively evaluated PCNL patients' QOL through the Wisconsin Stone Quality of Life (WISQOL) survey and Patient-Reported Outcomes Measurement System (PROMIS) at routine perioperative visits. To assess any opioid reduction benefit of the ERAS protocol, we reviewed an age-matched historical cohort  = 66 (before ERAS implementation) to serve as a comparison cohort with respect to opioid usage. After an inception cohort of 95 patients, 55 ERAS patients remained available for assessment with the WISQOL and PROMIS surveys. In comparison with the non-ERAS cohort, the ERAS cohort represented larger stones, more supine positioning, higher blood loss, shorter hospital stay, and more use of access sheath. ERAS patients received a significantly lower amount of opioids compared with non-ERAS patients upon discharge narcotic usage (116.13 morphine milliequivalent [MME] 39.57 MME,  = 0.0001). Compared with their preoperative evaluation, the ERAS cohort had significantly improved QOL scores at 1 week, which sustained through 8 weeks postoperatively. Moreover, pain intensity and pain interference scores were improved at 8 weeks postoperatively for ERAS patients compared with their preoperative time point. We demonstrate that standardizing medications in early efforts toward a PCNL ERAS protocol is feasible and allows for reduced opioid use by patients while achieving early and sustained postprocedure QOL.

摘要

本过程改进项目的目的是确定手术加速康复(ERAS)方案对经皮肾镜取石术(PCNL)患者术后恢复期生活质量(QOL)和疼痛管理的影响。2020年7月,一家学术医疗中心制定了基于电子病历的PCNL患者ERAS医嘱方案。该方案采用了一种疼痛控制方案,旨在尽量减少术后阿片类药物的使用。我们通过威斯康星结石生活质量(WISQOL)调查和患者报告结局测量系统(PROMIS)在围手术期常规访视中对PCNL患者的生活质量进行了前瞻性评估。为了评估ERAS方案在减少阿片类药物使用方面的益处,我们回顾了一个年龄匹配的历史队列(n = 66,ERAS实施前),作为阿片类药物使用方面的比较队列。在95例患者的起始队列之后,55例ERAS患者仍可通过WISQOL和PROMIS调查进行评估。与非ERAS队列相比,ERAS队列的结石更大,仰卧位时间更长,失血量更多,住院时间更短,鞘管使用更多。出院时,ERAS患者的阿片类药物使用量明显低于非ERAS患者(116.13吗啡毫克当量[MME]对39.57 MME;P = 0.0001)。与术前评估相比,ERAS队列在术后1周时生活质量评分显著提高,并持续至术后8周。此外,与术前时间点相比,ERAS患者在术后8周时的疼痛强度和疼痛干扰评分有所改善。我们证明,在早期努力制定PCNL的ERAS方案时规范用药是可行的,并且可以减少患者的阿片类药物使用,同时实现术后早期和持续的生活质量改善。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验